SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-14-002793
Filing Date
2014-10-24
Accepted
2014-10-23 21:30:57
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q medizone10q093014.htm 10-Q 391017
2 EX-31.1 ex31-1.htm EX-31.1 10260
3 EX-31.2 ex31-2.htm EX-31.2 10213
4 EX-32.1 ex32-1.htm EX-32.1 4308
5 EX-32.2 ex32-2.htm EX-32.2 4543
  Complete submission text file 0001185185-14-002793.txt   2554943

Data Files

Seq Description Document Type Size
6 EX-101.INS mzei-20140930.xml EX-101.INS 314212
7 EX-101.SCH mzei-20140930.xsd EX-101.SCH 25916
8 EX-101.CAL mzei-20140930_cal.xml EX-101.CAL 22649
9 EX-101.DEF mzei-20140930_def.xml EX-101.DEF 133056
10 EX-101.LAB mzei-20140930_lab.xml EX-101.LAB 186746
11 EX-101.PRE mzei-20140930_pre.xml EX-101.PRE 133465
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 141171021
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries